Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

27%

4 trials in Phase 3/4

Results Transparency

44%

4 of 9 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (3)
P 1 (4)
P 2 (2)
P 3 (2)
P 4 (2)

Trial Status

Completed9
Not Yet Recruiting3
Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06563102Phase 4CompletedPrimary

Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma

NCT02892344Phase 3CompletedPrimary

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

NCT06433921Phase 1Recruiting

A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

NCT07143747Not Yet RecruitingPrimary

PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

NCT04912596Not ApplicableRecruitingPrimary

Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

NCT06618105Phase 3Not Yet RecruitingPrimary

Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd

NCT06411886Not ApplicableNot Yet RecruitingPrimary

Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma

NCT04796844Recruiting

MANI Real-life Perspective Observatory

NCT03838731Phase 2Completed

Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge

NCT03421730Phase 1Completed

A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma

NCT00287365Not ApplicableCompletedPrimary

Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers

NCT00466596Phase 1Completed

Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements

NCT00448851Phase 1CompletedPrimary

Study of Dust Mite Inhalation in Humans

NCT00453778Phase 4Completed

A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients

NCT00380354Phase 2Completed

Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma

Showing all 15 trials

Research Network

Activity Timeline